7 completed, 4 unknown, 3 recruiting, 2 terminated. 19 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 19 | Completed 7, Unknown 4, Recruiting 3, Terminated 2, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1 |
Follow Suspensions: new trials by email Literature Review of Suspensions trials Research Report on Suspensions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Success Rates and Safety of Steroid Injections in Managing Spinal and Sacro-Iliac Pain (CORTisone Injection Spine Study) triamcinolone acetonide (Kenalog), Celestone Soluspan 6Mg/Ml Suspension for Injection, Depo-Medrol 40Mg/Ml Suspension for Injection - Back Pain Lower Back, Neck Pain | Phase 4 | Recruiting | Igor Wilderman. MD | 500 | 2026-07-30 | 2026-08-13 |
| Effects of Saccharomyces Boulardii CNCM I-745 on Antibiotic-Associated Perturbation in Children Treated for Acute Respiratory Infections (RESTORE Study) Amoxicillin-Clavulanic acid 600mg - 42.9 mg/ 5 mL oral suspension, Saccharomyces boulardii CNCM I-745 - Antibiotic Associated Diarrhea, Acute Otitis Media | Phase 4 | Completed | Eskisehir Osmangazi University | 100 | 2025-08-01 | 2026-09-11 |
| Comparison of Intralesional Triamcinolone Versus Verapamil for Keloid Treatment Triamcinolone Acetonide 1 ml of 40 mg/mL suspension, Verapamil Injection - Keloid Scars | Phase 4 | Not yet recruiting | Nishtar Medical University | 60 | 2025-04-01 | 2025-04-01 |
| A Study on Safety and Effectiveness of Long-term Treatment With Vamorolone in Boys With Duchenne Muscular Dystrophy vamorolone 40 mg/mL oral suspension - Duchenne Muscular Dystrophy | Phase 4 | Active not recruiting | Santhera Pharmaceuticals | 80 | 2024-11-10 | 2026-04-23 |
| Azithromycin for Child Survival in Niger II Azithromycin for Oral Suspension - Mortality, Antimicrobial Resistance | Phase 4 | Recruiting | University of California, San Francisco | 3300000 | 2024-04-29 | 2026-08-17 |
| Azithromycin for Child Survival in Niger: Programmatic Trial (AVENIR) Azithromycin for Oral Suspension - Resistance Bacterial, Morality | Phase 4 | Terminated | University of California, San Francisco | 169707 | 2022-12-01 | 2025-03-28 |
| A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic Hyperkalemia LOKELMA 5 GM Powder for Oral Suspension - Hyperkalemia | Phase 4 | Completed | NephroNet, Inc. | 88 | 2022-04-14 | 2024-06-05 |
| Azithromycin for Child Survival in Niger: Delivery Trial Azithromycin for Oral Suspension - Mortality, Child Health | Phase 4 | Completed | University of California, San Francisco | 10925 | 2021-06-28 | 2025-04-24 |
| Micronized and Ultramicronized Palmitoylethanolamide in COVID-19 Patients Micronized and ultra-micronized Palmitoylethanolamide (mPEA and umPEA, 300mg + 600mg) oral suspension, Standard Therapy - Covid19 | Phase 4 | Completed | Epitech Group SpA | 40 | 2020-10-23 | 2021-08-25 |
| Triamcinolone Injections for Persistent Choroidal Effusions Post Glaucoma Surgery Triamcinolone Acetonide 1 ml of 40 mg/mL suspension, Sham - Participants will not recieve the Triamcinolone Acetonide - Glaucoma, Choroidal Effusions | Phase 4 | Unknown | Sunnybrook Health Sciences Centre | 20 | 2020-10-14 | 2022-05-04 |
| Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management Patiromer Powder for Oral Suspension [Veltassa], Placebo - Hyperkalemia | Phase 4 | Terminated | Comprehensive Research Associates | 115 | 2020-10-08 | 2023-08-31 |
| The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and Hyperkalemia LOKELMA 5 GM Powder for Oral Suspension, Placebos - Type 2 Diabetes Mellitus With Kidney Complications | Phase 4 | Unknown | Steno Diabetes Center Copenhagen | 20 | 2019-10-01 | 2019-10-16 |
| Paracetamol Study in Patients With Low Muscle Mass Paracetamol 120Mg/5mL Oral Suspension - SMA II, Cerebral Palsy | Phase 4 | Unknown | Mette Cathrine Oerngreen | 48 | 2019-02-18 | 2024-02-22 |
| Post Intravitreal Injection Topical NSAID vs. Patching nepafenac 0.3% suspension (Ilevro; Alcon, Fort Worth, TX), Theratears tear drop, (Akron, Ann 111 Arbor, MI), patching - Neovascular Age-related Macular Degeneration, Diabetic Macular Edema | Phase 4 | Unknown | The New York Eye & Ear Infirmary | 60 | 2018-12-03 | 2019-04-17 |
| CEUS for Blunt Abdominal Trauma in Children Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Intravenous Powder for Suspension [LUMASON], contrast-enhanced ultrasound - Trauma Abdomen | Phase 4 | Recruiting | Children's Hospital of Philadelphia | 146 | 2018-06-01 | 2025-12-17 |
| Contrast Enhanced Ultrasound Evaluation of Brain Perfusion in Neonatal Post-Hemorrhagic Hydrocephalus Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Intravenous Powder for Suspension [LUMASON] - Neonatal Post-Hemorrhagic Hydrocephalus | Phase 4 | Withdrawn | Johns Hopkins University | 2017-04-01 | 2018-01-25 | |
| Patiromer With or Without Food for the Treatment of Hyperkalemia patiromer - Hyperkalemia | Phase 4 | Completed | Relypsa, Inc. | 114 | 2016-02-01 | 2021-05-12 |
| Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris Taclonex - Plaque Psoriasis | Phase 4 | Completed | Wake Forest University | 20 | 2012-10-01 | 2018-09-10 |
| Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation spinosad - Pediculosis | Phase 4 | Completed | ParaPRO LLC | 26 | 2011-09-01 | 2012-11-22 |
Hyperkalemia (4) · Abdominal Injuries (1) · COVID-19 (1) · Cerebral Palsy (1) · Choroidal Effusions (1) · Emergencies (1) · Failed Back Surgery Syndrome (1) · Glaucoma (1) · Keloid (1) · Lice Infestations (1) · Low Back Pain (1) · Muscular Dystrophy, Duchenne (1) · Neck Pain (1) · Osteoarthritis, Spine (1) · Otitis Media (1)
University of California, San Francisco (3) · Children's Hospital of Philadelphia (1) · Comprehensive Research Associates (1) · Epitech Group SpA (1) · Eskisehir Osmangazi University (1) · Igor Wilderman. MD (1) · Johns Hopkins University (1) · Mette Cathrine Oerngreen (1) · NephroNet, Inc. (1) · Nishtar Medical University (1) · ParaPRO LLC (1) · Relypsa, Inc. (1) · Santhera Pharmaceuticals (1) · Steno Diabetes Center Copenhagen (1) · Sunnybrook Health Sciences Centre (1)
United States (8) · Canada (2) · Denmark (2) · Niger (2) · Belgium (1) · Czechia (1) · Greece (1) · Ireland (1) · Israel (1) · Italy (1) · Netherlands (1) · New Zealand (1) · Pakistan (1) · Spain (1) · Turkey (Türkiye) (1)
Aaron E Chen, MD (1) · Adele R Clark, PA-C (1) · Alan B Fleischer, Jr, M.D. (1) · Catherine M Birt, MD FRCSC (1) · Dowling B Stough, M.D. (1) · Dr. Aliya Akhtar, FCPS (1) · Igor Wilderman, MD (1) · James Tumlin, MD (1) · Jeffrey C Seiler, M.D. (1) · Jeremy Whitson, BS (1) · Kieran O'Brien, PhD, MPH (1) · Kieran S O'Brien, PhD (1) · Kieran S O'Brien, PhD, MPH (1) · Misun Hwang, M.D. (1)
PMID 32588430, PMID 37308268, PMID 37967058, PMID 40585143, PMID 41709349, PMID 41730555
2018 (1), 2019 (1)